A Mathematical Programming Formulation for the Budding Yeast Cell Cycle by Panning, Thomas D. et al.
A Mathematical Programming Formulation for the Budding Yeast Cell Cycle
by
Thomas D. Panning∗, Layne T. Watson†, Clifford A. Shaffer∗, John J. Tyson‡
May 2, 2007
∗Department of Computer Science
†Departments of Computer Science and Mathematics
‡Department of Biological Sciences
Virginia Polytechnic Institute and State University
Blacksburg, VA 24061
1
Abstract. The budding yeast cell cycle can be modeled by a set of ordinary differential
equations with 143 rate constant parameters. The quality of the model (and an associated vector of
parameter settings) is measured by comparing simulation results to the experimental data derived
from observing the cell cycles of over 100 selected mutated forms. Unfortunately, determining
whether the simulated phenotype matches experimental data is difficult since the experimental
data tend to be qualitative in nature (i.e., whether the mutation is viable, or which development
phase it died in). Because of this, previous methods for automatically comparing simulation results
to experimental data used a discontinuous penalty function, which limits the range of techniques
available for automated estimation of the differential equation parameters. This paper presents a
system of smooth inequality constraints that will be satisfied if and only if the model matches the
experimental data. Results are presented for evaluating the mutants with the two most frequent
phenotypes. This nonlinear inequality formulation is the first step toward solving a large-scale
feasibility problem to determine the ordinary differential equation model parameters.
Keywords: systems biology, regulatory networks, eukaryote, nonlinear inequalities, feasibility
problem
1. Introduction
Molecular cell biology describes how cells convert genes into behavior. This description includes
how a cell creates proteins from genes, how those proteins interact, and how networks of inter-
acting proteins determine physiological characteristics of the cell. The central biological question
addressed here is how protein interactions regulate the cell cycle of budding yeast (Saccharomyces
cerevisiae).
The budding yeast cell cycle consists of four phases (see Figure 1), with cell division occurring
in the final phase. A newborn cell starts in G1 phase (unreplicated DNA), during which time it
grows to a sufficiently large size to warrant a new round of DNA synthesis (S phase). After DNA
synthesis has completed, the cell passes briefly through G2 phase (replicated DNA) and then enters
M phase (mitosis, where the two copies of each DNA molecule are separated and the cell divides,
creating two new cells that are in G1 phase).
Figure 1. The phases and stages of the cell cycle. The four phases of the cell cycle are
shown above the five stages. The events that delineate the cell cycle are at the bottom.
2
The protein interactions that govern these cell cycle events are modeled using differential
equations that describe the rate at which each protein concentration changes. In general, the
concentration of protein A, written as [A], changes according to the differential equation
d[A]
dt
= synthesis− degradation − binding + dissociation − inactivation + activation,
where “synthesis” is the rate at which new protein A molecules are synthesized from amino acids
(which depends on the concentration of active messenger RNA molecules for a particular protein),
“degradation” is the rate at which protein A is broken down into amino acids and polypeptide
fragments (which depends on the activity of specific proteolytic enzymes), “binding” is the rate at
which protein A combines with other molecules to form distinct molecular complexes, “dissociation”
is the rate at which these complexes break apart, “inactivation” is the rate at which certain post-
translational modifications (e.g., phosphorylation) of protein A are made, and “activation” is the
rate at which these modifications are reversed (e.g., dephosphorylation). Each of these rates is
itself a function of the concentrations of the interacting species in the network. For example,
synthesis = k1[transcription factor],
degradation = k2[proteolytic enzyme][A],
binding = k3[A][B],where B is a binding partner,
dissociation = k4[AB],
inactivation =
k5[kinase][A]
J5 + [A]
,
activation =
k6[phosphatase][Ap]
J6 + [Ap]
,where Ap is the phosphorylated form of A.
In these rate laws, the ks are rate constants and the Js are Michaelis constants. Other differ-
ential equations must be used to determine the temporal dynamics of the concentrations of the
“transcription factor,” “proteolytic enzyme,” “kinase,” etc.
A simple example illustrating the spirit of the modelling approach in this paper follows. A
rudimentary reaction network for the frog egg cell cycle [22] results in the three ordinary differential
equations
dM
dt
=
(
v′d(1−D) + v
′′
dD
)
(CT −M)−
(
v′w(1−W ) + v
′′
wW
)
M,
dD
dt
= vd
(
M(1−D)
Kmd + (1−D)
−
ρdD
Kmdr +D
)
,
dW
dt
= vw
(
−
MW
Kmw +W
+
ρw(1−W )
Kmwr + (1−W )
)
,
where M , D, and W are normalized protein concentrations, the Ks, ρs, and vs are rate constants,
and the constant CT is total (normalized) cyclin. For CT above some threshold CA, the cell enters
mitosis and cycles. Finding this threshold and the periodic solution defining the cell cycle could
be modelled by the system of constraints
0 < τ < t1,
M(t1) =M(t1 + τ) =M(t1 + 2τ),
dM
dt
(t1) =
dM
dt
(t1 + τ) =
dM
dt
(t1 + 2τ),
CA < CT ,
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where the variables would be a time t1, a period τ , and a threshold CA.
The budding yeast cell cycle model [7] consists of 36 such differential equations for two classes
of variables: regulatory proteins and physiological “flags.” The regulatory proteins are triggers for
specific events of the budding yeast cell cycle: Cln2 triggers budding, Clb5 triggers DNA synthesis,
Clb2 drives cells into mitosis, and Esp1 drives cells out of mitosis and back to G1. The physiological
“flags” are dummy variables that track the strength of these trigger proteins. For example, “BUD”
is an integral of the activity of Cln2; when BUD = 1, a new bud is initiated. “ORI,” an integral of
[Clb5], represents the state of “origins of replication.” When ORI = 1 (this state is called “fired”
origins), DNA synthesis is initiated; at cell division, when [Clb2] + [Clb5] drops below a threshold
level, ORI is reset to zero (called “licensed” origins). Finally, “SPN” represents the alignment of
replicated chromosomes on the mitotic spindle. SPN is driven by Clb2 activity; i.e., SPN is an
integral of [Clb2].
In the budding yeast model there are 143 rate constant parameters (ks, Js, etc.). In some cases,
these parameters can be calculated directly from laboratory experiments (e.g., apparent protein
half-lives), but most parameters are difficult to obtain directly from experimentation. Normally,
modelers determine the remaining parameters by making educated guesses, solving the differential
equations numerically, comparing the simulation results with laboratory data, and then refining
their guesses. (Modelers call this process “parameter twiddling” [2].) For the budding yeast cell
cycle, the laboratory data consists of observed phenotypes of more than 100 mutant yeast strains
constructed by disabling and/or over-expressing the genes that encode the proteins of the regulatory
network.
Although parameter twiddling is extremely tedious, it was used to obtain a parameter vector
(s1, s2, . . . , s143) for which the model’s predictions are consistent with almost all of the budding
yeast mutants being modeled. Obviously, the modelers would prefer a method that allows them
to spend more time improving the equations and less time tuning parameters. In addition, a
person can only keep track of a few parameters at one time, which makes it easy for him or her
to unwittingly miss a portion of the parameter space. For these reasons, modelers would prefer to
use a tool that determines “good” parameters automatically, quickly, and accurately.
The current approach to this parameter estimation (nonlinear regression) problem is to assign
a penalty to every discrepancy between the ordinary differential equation (ODE) model’s predic-
tions and experimental data, using all available mutant data, and then do an unconstrained (or
simple bound constrained) minimization of this penalty function over the ODE parameter space
([6], [8], [18], [21]). Due to the qualitative nature of the experimental data (Section 2), some of
these penalties are discrete and this penalty function is inherently discontinuous, while the ODE
solution is a smooth function of the ODE parameters. Beyond the fact that discontinuous objec-
tive functions are difficult to minimize, either locally or globally, this penalty approach has deeper
flaws. Biologists do not agree on what the penalty should be for a particular discrepancy, or even
on which discrepancies should be penalized.
This paper takes a quite different approach to parameter estimation. The idea is to describe
the mutant data as a system of smooth nonlinear inequalities derived from the (smooth) ODE
model output and cell biology knowledge. These inequalities should be generally accepted by
cell biologists, even though some of the details may be debatable. An ODE parameter vector
that satisfies all of the inequalities thus defines an acceptable model, and is a feasible solution of
the system of inequalities. The proposed approach to parameter estimation is to solve a feasibility
problem defined by a system of smooth (continuous, piecewise C∞) inequalities. One could surmise
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that what really is desired is the “most interior” point, defined by, e.g., constraint margins. The
situation is not so simple, though, since a cell’s viability is robust with respect to environmental
variations, and therefore it is really the “most robust” feasible point that is sought. Modeling such
biological robustness is another research topic.
The paper is organized as follows. After some definitions, Section 2 provides the necessary
biology background. As a point of reference, Section 3 describes the penalty function model, and
reports parallel computing results obtained on the 2200 processor System X. Section 4 presents the
inequality models for all the mutants, the heart of the paper. Some preliminary numerical results
for the model are given in Section 5, but an attempt to solve the full model (with approximately
11,500 constraints and 4,000 variables) is a major long term project.
2. Observed and Predicted Phenotypes
Experimental biologists have studied many budding yeast mutants to learn about the cell cycle
regulatory system. Of these mutants, 115 were chosen to model (see Appendix A). A model of
budding yeast can be considered acceptable only if it is able to duplicate the behavior of most of
these mutants. (It would be too much to expect a model to account for all the “observations” be-
cause of lingering uncertainties about the reaction network and inevitable mistakes in phenotyping
mutants.) When the model is used to simulate a mutant, the parameter vector can be changed
only in ways that are dictated by the genetic changes in the mutant. Consider the hypothetical
proteins A and B presented in the previous section: if a mutant has a modified form of B that does
not bind to A, then in the parameter vector for that mutant, k3 would be set to zero and all the
other parameters would be kept at the wild type values.
The observed phenotype refers to the phenotype that was recorded in a laboratory experiment.
The predicted phenotype refers to the phenotype that the mathematical model (with its associated
parameters) predicts. The wild type is the normal strain of an organism. The mutant strains have
genetic changes that make them behave differently from the wild type in some way.
When comparing the model to the experimental data, it is important to realize that much of
the data from laboratory experiments is qualitative. Such data is of the form “the cell is viable but
considerably larger than wild type cells” or “the cell arrests in G1 phase and eventually dies.” The
quantitative data that is available (e.g., duration of G1 phase, cell mass at division) is generally
imprecise. With all these uncertainties, there may be many, clustered parameter vectors that allow
the model to reproduce the experimental data sufficiently well. What matters for the model here
is the structure of the cell cycle regulatory pathways, not the details of the biochemistry.
2.1 Rules of Viability
To compare solutions of the differential equations with experimental data, it is necessary to predict
cell cycle properties from a simulation of regulatory protein dynamics. Viability is determined by
four rules:
1. The modeled cell must execute the following events in order, or else the modeled cell is
considered inviable:
(a) DNA licensed for replication (modeled by a drop in [Clb2] + [Clb5] below Kez2, which
resets [ORI] to zero);
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(b) start of DNA synthesis (due to a subsequent rise in [Clb2] + [Clb5], causing [ORI] to
increase above one), signaling the end of G1 phase, before a wild-type cell in the same
medium would divide twice;
(c) alignment of DNA copies (due to a rise in [Clb2], causing [SPN] to increase above one)
while [Esp1] is less than 0.1;
(d) separation of DNA copies (modeled by [Esp1] increasing above 0.1, due to Pds1 proteolysis
at anaphase);
(e) cellular division (modeled by [Clb2] dropping below a threshold Kez), which resets [BUD]
and [SPN] to zero.
2. The cell is inviable if division occurs in an “unbudded cell” (i.e., if [BUD] does not reach the
value 0.8 before event (e) occurs).
3. The cell cycle should be stable, i.e., the squared relative differences of the masses and G1
phase durations in the last two simulated cycles should both be less than 0.05.
4. Lastly, the modeled cell is considered inviable if cell mass at division is greater than four times
or less than one-fourth times the steady-state mass at division of the wild type in the same
medium.
If the observed phenotype for a mutant does not complete one of the checkpoints (e.g., the
mutant cells do not bud), then the predicted phenotype of that mutant must exhibit the same
behavior. It is possible for a cell to complete all of the checkpoints in the first cycle and then
become arrested somewhere in the second cycle. If a cell has this type of observed phenotype, then
a correct model must predict the same number of cycles before arresting in the same manner. If
the observed cell has a viable phenotype, then the model must predict a viable cell with a similar
G1-phase length, and a similar mass at division.
2.2 Initial Conditions
In the experimental data set, many of the mutations are conditional, that is, the mutant cells
when grown under “normal” conditions (say, glucose medium at room temperature) behave like
wild-type cells, but when grown under “restrictive” conditions (say, galactose medium or elevated
temperature) the cells express the genetic mutation and the aberrant phenotype. To model this
situation at sample points in parameter space, start a “wild-type” simulation from arbitrary (but
reasonable) initial conditions and integrate the differential equations for two full cycles, in order
to wash out any effects of the initial conditions. Then record the state of the control system just
after [Clb2] + [Clb5] falls through Kez2 at the beginning of the third cycle. These recorded values
are used as initial conditions for simulating a steady state wild-type cell and for simulating each
of the mutants.
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3. Nonsmooth Penalty Function Formulation
This section describes a typical deviation (model prediction minus observed system response)
based formulation of the parameter identification problem as the unconstrained (or at most simple
bound constrained) minimization of a nonsmooth objective function. Numerical results using 1024
processors are presented for two different applicable optimization algorithms. Since these runs
required many hours on 1024 processors, the need for high performance computing for the smooth
inequality formulation in the next section should be clear.
The objective function takes the observed phenotype and predicted phenotype for all of the
mutants and computes a nonnegative score. Zero indicates a perfect match and larger numbers
indicate increasingly worse matches. The ensuing discussion uses the symbol O for observed phe-
notype values and P for predicted phenotype values.
A budding yeast phenotype for a single mutant is represented by a six-tuple (v, g, m, a, t,
c), where the viability v ∈ {viable, inviable}, the real number g > 0 is the steady state length of
the G1 phase, the real number m > 0 is the steady state mass at division, the stage when arrest
occurred is
a ∈ {unlicensed, licensed, fired, aligned, separated},
the positive integer t is the arrest type, and the nonnegative integer c is the number of successful
cycles completed. The observed and predicted phenotypes are writtenO = (Ov, Og, Om, Oa, Ot, Oc)
and P = (Pv , Pg, Pm, Pa, Pt, Pc), respectively. Arrest types cannot be compared unless the stage
of arrest is the same for both phenotypes.
In what follows, the ωs and σs are constants defined in Table 1. The rating function, R,
compares the observed and predicted phenotypes for a mutant. This rating function is a modified
version of the one developed by N. Allen et al. [3]; the only difference is that if Ov or Pv is missing,
then R(O,P ) = ωv. The rating function is split into four cases depending on the viability of
the observed and predicted phenotypes. If Ov = inviable, Pv = viable, and Oc is missing, then
R(O,P ) = ωv, the same as if Oc = 0. Otherwise, if a needed classifier is missing, the term is simply
dropped and does not contribute to the objective function. In the case that classifiers are missing,
this allows the objective function value to be at or near zero when viability is in agreement between
the phenotypes, and forces larger objective function values when viability is not in agreement.
The rating function R(O,P ) when all classifiers are present is given by
ωg ×
(
Og − Pg
σg
)2
+ ωm ×
(
ln Om
Pm
σm
)2
,
if Ov = viable and Pv = viable, by
ωv ×
1
1 + Pc
,
if Ov = viable and Pv = inviable, by
δO,P + ωc ×
(
Oc − Pc
σc
)2
,
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if Ov = inviable and Pv = inviable, and by
ωv ×
1
1 +Oc
,
if Ov = inviable and Pv = viable, where δ is a real valued discrete function, used to assess a penalty
for the arrest stage and type, given by
δO,P =
{
ωa, if Oa 6= Pa,
ωt, if Oa = Pa and Ot 6= Pt,
0, if Oa = Pa and Ot = Pt.
The rating function is tuned by parameters to allow the modeler to adjust the relative im-
portance of classifiers. The parameters given by Table 1 were set so that a rating of around ten
indicates a critical error in the model’s prediction of a phenotype.
Symbol Definition Value
ωg G1 length weight 1.0
σg G1 length scale 10.0
ωm Mass at division weight 1.0
σm Mass at division scale ln 2
ωa Arrest stage weight 10.0
ωt Arrest type weight 5.0
ωc Cycle count weight 10.0
σc Cycle count scale 1.0
ωv Viability weight 40.0
Table 1. Constants used in objective function.
Denote the real numbers by R, the nonnegative integers {0, 1, 2, . . .} by Z+, and the integers
by Z. Let
P = (v, g,m, a, t, c)
= {viable, inviable} × (0,∞)2
× {unlicensed, licensed,fired, aligned, separated}
× {1, . . . , 10} × Z+
be the space of all budding yeast phenotypes and let the domain of the objective function be the
box
Ω = {x ∈ R143 : si/ui ≤ xi ≤ si × ui,
i = 1, . . . , 143},
where u ∈ R143 are positive scale factors reflecting modelers’ knowledge about the rate constants,
and s ∈ R143 is the modeler’s best guess point. Let Tj : Ω→ P simulate the jth mutant with the
parameters x1, . . . , x143 and compute the phenotype. Then the objective function f : Ω → [0,∞)
is defined by
f(x) =
Nm∑
j=1
µjR(Oj , Tj(x)),
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where Nm is the number of mutant experiments, and µi ∈ {1, 4} is a weight that indicates whether
the ith mutant is of normal or high importance. The objective function value at the biologists’
best previously known point [7] is 433.
Two algorithms that show promise for optimizing the discontinuous objective function are
briefly described next. Consider the problem of minimizing f : B → R, where B = [l, u] ⊂ Rn is
a box.
3.1 DIRECT
The DIRECT (Dividing Rectangles) global minimization algorithm [14] requires the objective
function to be Lipschitz continuous to guarantee convergence. Even though the objective func-
tion used here is discontinuous, the DIRECT algorithm seems to be an efficient and reasonable
deterministic sampling strategy worth trying.
The DIRECT algorithm is one of a class of deterministic direct search algorithms that does
not require gradients. It works by iteratively dividing the search domain into boxes that have
exactly one function value at the box’s center. In each iteration, the algorithm determines which
boxes are most likely to contain a better point than the current minimum point—these boxes
are called “potentially optimal”. It then subdivides the potentially optimal boxes along their
longest dimensions. Intuitively, a box is considered potentially optimal if it has the potentially
best function value for a given Lipschitz constant.
For an illustration of how the DIRECT algorithm searches the domain on an example problem,
see [20]. Both serial [10] and parallel ([11]–[13]) versions of DIRECT have been described in the
literature.
3.2 MADS
A MADS (Mesh Adaptive Direct Search) algorithm, as defined by Audet and Dennis [5],
minimizes a nonsmooth function f : Rn → R ∪ {+∞} under general constraints x ∈ Ω ⊆ Rn,
Ω 6= ∅. If Ω 6= Rn, the algorithm works with fΩ, which is equal to f on Ω and +∞ outside Ω.
Using fΩ in lieu of f is called a “barrier” approach to handling arbitrary constraints x ∈ Ω.
In each iteration, a MADS algorithm evaluates the objective function fΩ at a finite number
of trial points. Central to these algorithms is the concept of a mesh, which is a discrete set of
points in Rn. Every previous trial point must lie on the current mesh, and in each iteration the
algorithm may only generate new trial points on the current mesh. This is not as restrictive as
it might sound because the algorithm changes the mesh after each iteration (with the restriction
that at iteration k all previously evaluated points Sk remain in the new mesh).
Each iteration of a MADS algorithm consists of two steps: the search step and the poll
step. The search step may evaluate fΩ at any finite number of mesh points. At which mesh
points fΩ is evaluated depends on the precise MADS algorithm in use. If the search step fails to
find a mesh point at which fΩ is less than minx∈Sk fΩ(x), then the algorithm performs the poll
step by generating and evaluating fΩ at new trial points around the current incumbent solution
xk, where fΩ(xk) = minx∈Sk fΩ(x). The poll size parameter ∆
p
k limits the distance between xk
and the new trial points. The set of new trial points is called a frame, and xk is called the frame
center. The algorithm evaluates fΩ at points in the frame Pk until it encounters an improved point
x∗ (fΩ(x
∗) < fΩ(xk)) or it has evaluated fΩ at all of the points in Pk.
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Figure 2. The objective function value at the best point found versus the number of
evaluations for MADS and DIRECT.
After the algorithm has executed the search step and (conditionally) the poll step, it sets
the mesh size and poll size parameters, ∆mk+1 and ∆
p
k+1, for the next iteration. Exactly how ∆
m
k+1
and ∆pk+1 are generated is determined by the individual algorithm in use. More precise descriptions
of the MADS class of algorithms with examples can be found in [5] or [18].
3.3 Parallel Optimization Results
All computation took place on System X, a cluster of 1100 dual-processor Mac G5 nodes.
NOMAD is a C++ implementation of the MADS class of algorithms. To take advantage of
System X, NOMAD’s implementation of the poll step was parallelized using a master/worker
paradigm. The master ran the MADS algorithm as presented and sent requests to the workers
whenever objective function values were needed. NOMAD, started from the modeler’s best point s,
evaluated the objective function 135,000 times over 813 iterations using 128 processors, converging
at a point for which the objective function value was 299 (this point correctly models all but ten
of the mutants).
pVTDirect [11] is a parallel implementation of DIRECT written in Fortran 95. While the
DIRECT algorithm does not have a traditional “starting point”, the first sample in each subdomain
is always taken at the center of the subdomain bounding box. For this problem, the bounding box
was designed so that the modeler’s best point would be at the center and therefore would be
evaluated before any other points. pVTDirect (with only one subdomain) ran for 473 iterations
using 1024 processors and evaluated the objective function 1.5 million times, finding a point at
which the objective function value was 212 (this point correctly models all but eight of the mutants).
Figure 2 shows the progress that each program was able to make in minimizing the objective
function. While NOMAD was able to quickly find a better point than the modeler’s best point,
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Figure 3. The performance of NOMAD when started from the best point at pVTDirect’s
54th, 157th, and 239th iterations. The plots are shown as if the NOMAD runs started as
soon as the respective pVTDirect iterations completed.
pVTDirect was eventually able to find an even lower point. This is expected behavior because
NOMAD is designed for local optimization and pVTDirect is designed for global optimization,
so NOMAD quickly found a nearby local minimum and stopped, but pVTDirect explored the
parameter space and eventually found a better minimum. In a later run, NOMAD was started
from pVTDirect’s lowest point, but NOMAD was unable to make any further progress. After
looking at Figure 2, it is tempting to believe that pVTDirect could have been stopped earlier (for
instance, after 200,000 evaluations), and NOMAD started at pVTDirect’s last best point could
have found a point at which the objective function value was 212 or less. To test this, NOMAD
was started at the best point at the 54th, 157th, and 239th iterations of pVTDirect. These points
correspond to the beginning, middle, and end of the second-lowest plateau in Figure 2. As shown
in Figure 3, NOMAD started from the middle point converged to a point at which the objective
function value was 210. However, the NOMAD runs started at the beginning and end plateau
points converge to worse points than pVTDirect’s best point. These four extra NOMAD runs
(including the one starting from pVTDirect’s best point) show that an algorithm for improving
intermediate results from pVTDirect is not so clear.
Finally, recall that f(x) > 0 means some mutant experimental data is not being matched,
i.e., the parameters found by DIRECT and MADS do not fully explain all the data. These results
motivated the smooth inequality formulation given next.
4. Formulation of Conditions as a Nonlinear System of Inequalities
For each phenotype, this section presents a system of constraints that will be satisfied if and only if
the simulation predicts the same phenotype. The constraints are written using as much biological
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notation as possible, so [Esp1](t6) refers to the concentration of the protein Esp1 at the time t6.
The constraints include time variables ti where i is a positive integer; although these variables are
not part of the model, they must still be found by the parameter estimator. In the constraints,
there are several constants which are set as follows: ǫ = 0.05, δG1 = 20, and δM = 1.4.
4.1 Viable Phenotype Constraints
The constraints for a viable cell to go through one cycle are listed below, with annotations denoted
by angle brackets.
t1 < t2 < t3 < t4 < t5 < t6 < t8, 〈1〉
t3 − t1 < tw, 〈2〉
t2 < t7 < t8, 〈3〉
G1 − δG1 < t3 − t0 < G1 + δG1 , 〈4〉
min
t1≤t≤t2
([Clb2](t) + [Clb5](t)) > Kez2 > [Clb2](t2 + ǫ) + [Clb5](t2 + ǫ), 〈5〉
max
t2+ǫ≤t≤t3
[ORI](t) < 1 < [ORI](t3 + ǫ), 〈6〉
max
t1≤t≤t4
[SPN](t) < 1 < [SPN](t5), 〈7〉
max
t4≤t≤t5
[Esp1](t) < 0.1 < [Esp1](t6), 〈8〉
[BUD](t7) > 0.8, 〈9〉
[Clb2](t8 − ǫ) > Kez > [Clb2](t8), 〈10〉
max
t1≤t≤t8−ǫ
[mass](t) < 4mw, 〈11〉
M − δM < [mass](t8 − ǫ) < M + δM . 〈12〉
〈1〉 These strict inequalities ensure the correct temporal ordering of the events defined by the times
ti. 〈2〉 [ORI] must rise above one before a wild type cell would divide twice in the same medium
(e.g., glucose or galactose); tw is set to the amount of time a simulated wild type cell takes to
divide twice with the same biological parameters. 〈3〉 t7 (which marks [BUD] rising above one)
simply has to occur any time between t2 and t8. 〈4〉 G1 is the length of the G1-phase, as observed
in experiments. This ensures that the simulated cell is within a predefined distance δG1 of the
observed value. 〈5〉 [Clb2] + [Clb5] drops, satisfying viability rule 1(a). 〈6〉 [ORI] rises, satisfying
rule 1(b). 〈7〉 [SPN] rises, satisfying rule 1(c). 〈8〉 [Esp1] rises, satisfying rule 1(d). 〈9〉 [BUD]
rises, satisfying rule 2. 〈10〉 [Clb2] drops, satisfying rule 1(e). 〈11〉 Mass is always less than four
times the mass of the wild type in the same medium; mw is the mass of a simulated wild type cell
with the same biological parameters. 〈12〉 M is the observed mass at division.
A cell that meets the above constraints is viable for one cycle. For the first cycle, remember that
the starting conditions are just after [Clb2] + [Clb5] dropped through Kez2, so the fifth constraint
must be omitted. For the rest of the cycles, repeat the constraints with variables t1+7(n−1),
t2+7(n−1), . . ., t8+7(n−1) for cycle n. Note that the last time of the previous cycle is the first
time in the current cycle. To enforce the stability requirements, add the constraints
(
[mass](t8+7(N−2))− [mass](t8+7(N−1))
[mass](t8+7(N−2))
)2
< 0.05
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and (
(t3+7(N−2) − t1+7(N−2))− (t3+7(N−1) − t1+7(N−1))
(t3+7(N−2) − t1+7(N−2))
)2
< 0.05,
where N is the total number of cycles.
4.2 Phenotypes for pds1∆ Mutants
The pds1∆ mutants are incapable of synthesizing Esp1, but some of these mutants still manage to
separate the DNA copies. It is suspected that these mutants use a different mechanism to separate
the DNA, but that mechanism is not included in this model. So for the purposes of this model,
pds1∆ mutants are not required to meet viability rule 1(d), and the corresponding constraints
should be omitted when evaluating mutants 61, 62, 66, 67, 71, and 113 in Appendix A.
4.3 Inviable Phenotype Constraints
A cell that fulfills the above constraints is considered viable. Some of the mutants have an observed
phenotype of inviable, so their constraints will be different. The constraints for an inviable mutant
are determined by when and how the cell arrests. There are four major types of arrest stages: G1
arrest, metaphase arrest, G2 arrest, and telophase arrest. The following subsections present the
inequality constraints for each of these arrest types.
4.4 G1 Arrest
In terms of the model, a G1 arrest means that none of [ORI], [SPN], or [BUD] should rise to one
before the cell cycle is considered arrested. Whether or not [Clb2]+ [Clb5] drops below Kez has no
effect on whether the cell is G1 arrested, so it is not mentioned in the constraints. A cell arrests in
G1 either because its mass has become greater than 4mw (see viability rule 4) or because tw time
has passed (see checkpoint 1(b)). Constraints for a G1 arrested mutant are thus
max{t1 − tw, max
0≤t≤t1
[mass](t)− 4mw} > 0,
max
0≤t≤t1
[ORI](t) < 1,
max
0≤t≤t1
[SPN](t) < 1,
max
0≤t≤t1
[BUD](t) < 1.
The first inequality ensures that t1 is a time after the cell has arrested. Specifically, the quantity
t1 − tw will be greater than zero if a wild type cell could divide twice before t1. Similarly, the
quantity max0≤t≤t1 [mass](t)−4mw will be greater than zero if the cell has grown to a mass greater
than 4mw before t1. The maximum of these quantities is used because violating any of the viability
rules causes a cell to be arrested.
4.5 G2 Arrest
For a cell to be arrested in G2, it must execute the first two checkpoints of a viable cell, but [SPN]
must stay low.
t1 < t2 < t3 < t4,
t3 − t1 < tw,
min
t1≤t≤t2
([Clb2](t) + [Clb5](t)) > Kez2 > [Clb2](t2 + ǫ) + [Clb5](t2 + ǫ),
max
t2+ǫ≤t≤t3
[ORI](t) < 1 < [ORI](t3 + ǫ),
max
0≤t≤t4
[SPN](t) < 1,
max
0≤t≤t4
[mass](t) > 4mw.
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4.6 Metaphase Arrest
If a cell is arrested in metaphase, its chromosomes are aligned on its spindles (i.e., the [SPN]
checkpoint must be reached) but the chromosomes have not separated (i.e., Esp1 has not activated).
Metaphase arrested cells may be budded or unbudded. This means that the following constraints
must be met.
t1 < t2 < t3 < t4 < t5 < t6,
t3 − t1 < tw,
min
t1≤t≤t2
([Clb2](t) + [Clb5](t)) > Kez2 > [Clb2](t2 + ǫ) + [Clb5](t2 + ǫ),
max
t2+ǫ≤t≤t3
[ORI](t) < 1 < [ORI](t3 + ǫ),
max
t1≤t≤t4
[SPN](t) < 1 < [SPN](t5),
max
t4≤t≤t5
[Esp1](t) < 0.1,
max
0≤t≤t6
[mass](t) > 4mw.
4.7 Telophase Arrest
While the G1 phase is the earliest a cell can be arrested, telophase is the latest a cell can become
arrested. A telophase arrested cell must complete all of the checkpoints except that [Clb2] can
not drop below Kez before the cell arrests. The first eight constraints for such a cell would be the
same as the constraints for a viable cell. The ninth constraint would be removed, and the tenth
constraint would be changed to
max
t2+ǫ≤t≤t7
[Clb2](t) < Kez < min
t7+ǫ≤t≤t8
[Clb2](t),
with the additional constraints
t1 < t7 < t8,
[mass](t8) > 4mw.
4.8 Evaluating All of the Mutants
As described earlier, a parameter vector must satisfy all of the constraints for all of the mutants
before it can be considered feasible. Each mutant requires a separate simulation and will have its
own set of time variables derived from its concentrations’ trajectories. The mutants are numbered
as in Appendix A, so the time for the ith mutant will be t{i}. Also, because each mutant modifies
the parameter vector slightly, the concentration of a substance at a specific time will vary among
the mutants. Rather than explicitly specify which parameter vector is being used, the superscript
of the time will indicate the parameter vector being used. For instance, mutant 13 is a G1 arrested
mutant, so its constraints would be
max{t
{13}
1 − tw, max
0≤t{13}≤t
{13}
1
[mass](t{13})− 4mw} > 0,
max
0≤t{13}≤t
{13}
1
[ORI](t{13}) < 1,
max
0≤t{13}≤t
{13}
1
[SPN](t{13}) < 1,
max
0≤t{13}≤t
{13}
1
[BUD](t{13}) < 1.
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Table 2. The numbering of the viable constraints for Tables 4, 5, 6, and 7.
Index Constraint
1 t1 < t2
2 t2 < t3
3 t3 < t4
4 t4 < t5
5 t5 < t6
6 t1 < t7
7 t7 < t8
8 t6 < t8
9 t3 − t1 < tw
10 |t3 − t0 −G1| < δG1
11 G1 stability constraint
12 mint1≤t≤t2([Clb2](t) + [Clb5](t)) > Kez2
13 Kez2 > [Clb2](t2 + ǫ) + [Clb5](t2 + ǫ)
14 maxt2+ǫ≤t≤t3 [ORI](t) < 1
15 1 < [ORI](t3 + ǫ)
16 maxt1≤t≤t4 [SPN](t) < 1
17 1 < [SPN](t5)
18 maxt4≤t≤t5 [Esp1](t) < 0.1
19 0.1 < [Esp1](t6)
20 [BUD](t7) > 1
21 [Clb2](t8 − ǫ) > Kez
22 Kez > [Clb2](t8)
23 maxt1≤t≤t8−ǫ [mass](t) < 4mw
24
∣∣[mass](t8 − ǫ)/mw −M ∣∣ < δm
25 Mass stability constraint
5. Biological Results
To test this formulation, the constraints for the telophase arrest and viable phenotypes were
evaluated at two parameter vectors. The pds1∆ mutants were excluded from this test, leaving
61 mutants with an observed phenotype of viable and 15 mutants with an observed phenotype
of telophase arrested. The first parameter vector used the best manually obtained biological
parameters [7], and the second vector used the best biological parameters found using optimization
algorithms on a penalty function formulation of the problem [18].
For both vectors, the time parameters were found using an algorithm that examines the ODE
model simulation time series output and picks sensible values. In one pass through the simulation
time series output, this algorithm attempts to pick the time variables so that they are in the
proper order, and if possible, the constraints are satisfied. During the simulation, the algorithm
keeps track of the maximum and minimum values for the model variables in the constraints (e.g.,
[BUD], [SPN]). When an event (cf. Section 2.1) occurs, the algorithm sets the respective time
variables and then checks to see if all of the earlier time variables have been set. If there are earlier
time variables that have not been set, the algorithm attempts to set each of them to a time that
maintains the ordering of the variables and minimizes the violation of the constraints. A more
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Table 3. The numbering of the telophase arrest constraints for Tables 4, 5, 6, and 7.
Index Constraint
1 t1 < t2
2 t2 < t3
3 t3 < t4
4 t4 < t5
5 t5 < t6
6 t1 < t7
7 t7 < t8
8 maxt2+ǫ≤t≤t3 [ORI](t) < 1
9 1 < [ORI](t3 + ǫ)
10 maxt1≤t≤t4 [SPN](t) < 1
11 1 < [SPN](t5)
12 maxt4≤t≤t5 [Esp1](t) < 0.1
13 0.1 < [Esp1](t6)
14 maxt1+ǫ≤t≤t7 [Clb2](t) < Kez
15 Kez < mint7+ǫ≤t≤t8 [Clb2](t)
16 [mass](t8) > 4mw
formal description of this algorithm (for the viable phenotype) is given below (ǫ comes from the
beginning of Section 3). There is a similar algorithm for the telophase arrested phenotype.
check *: flags for checking earlier events
o: offset into the time parameters
nc: number of cycles completed
reset cycle: flag for resetting best times
s: maximum time that a previous event can be set to
t: current time
tf : end of the simulation time
tb: best time for [BUD] rising
tc: best time for [Clb2] + [Clb5] dropping
te: best time for [Esp1] rising
tr: best time for [ORI] rising
ts: best time for [SPN] rising
t := 0; nc := 0; o := 1; s := 0; tc := 0; tr := 0; ts := 0; te := 0; tb := 0
while (t < tf ) do
check Clb2 Clb5 := false; check ORI := false; check ORI := false; check SPN := false
check Esp1 := false; check BUD := false; reset cycle := false
if (nc > 1) then
o := 8 + (nc − 1)× 7
else
o := 1
end if
Advance t to the next time in the ODE simulation time series output.
if ([Clb2] + [Clb5] dropped through Kez2) then
to+1 := t− ǫ/2; tr := −1; ts := −1; te := −1
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elseif ([ORI] rose through one) then
to+2 := t− ǫ/2; s := to+2 − ǫ; ts := −1; te := −1; check Clb2 Clb5 := true
elseif ([SPN] rose through one) then
to+3 := t− ǫ; to+4 := t+ ǫ; s := to+3 − ǫ; te := −1; check ORI := true
elseif ([Esp1] rose through 0.1) then
to+5 := t+ ǫ; s := to+5 − ǫ; check SPN := true
elseif ([BUD] rose through one) then
to+6 := t+ ǫ
elseif ([Clb2] rose through Kez) then
to+7 := t− ǫ/2; nc := nc + 1; s := to+7 − ǫ
check Esp1 := true; check BUD := true; reset cycle := true
end if
if (check BUD = true and to+6 has not been set) then
if ([BUD](s) < [BUD](tb)) then
to+6 := tb
else
to+6 := s
end if
end if
if (check Esp1 = true and to+5 has not been set) then
if ([Esp1](s) < [Esp1](te)) then
to+5 := te
else
to+5 := s
end if
check SPN := true
end if
s := to+5 − ǫ
if (check SPN = true and to+4 has not been set) then
if ([SPN](s) < [SPN](ts)) then
to+3 := ts − ǫ; to+4 := ts + ǫ
else
to+3 := s− ǫ; to+4 := s+ ǫ
end if
check ORI := true
end if
s := to+3 − ǫ
if (check ORI = true and to+2 has not been set) then
if ([ORI](s) < [ORI](tr)) then
to+2 := tr
else
to+2 := s
end if
check Clb2 Clb5 := true
s := to+2 − ǫ
if (check Clb2 Clb5 = true and to+1 has not been set) then
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if ([Clb2](s) + [Clb5](s) > [Clb2](tc) + [Clb5](tc)) then
to+1 := tc
else
to+1 := s
end if
end if
if (reset cycle = true) then
tc := −1; tr := −1; ts := −1; te := −1; tb := −1
end if
if ([Clb2](t) + [Clb5](t) < [Clb2](tc) + [Clb5](tc) or tc < 0) then
tc := t
end if
if ([ORI](t) > [ORI](tr) or tc < 0) then
tr := t
end if
if ([SPN](t) > [SPN](ts) or tc < 0) then
ts := t
end if
if ([Esp1](t) > [Esp1](te) or tc < 0) then
te := t
end if
if ([BUD](t) > [BUD](tb) or tc < 0) then
tb := t
end if
end while
For conciseness, the violated constraints for viable mutants are listed as “Cx-Ny”, where x
indicates the cycle in which the violation occurred, and y is an index into Table 2 that indicates
which constraint was violated. The violated constraints for telophase-arrested mutants are listed
as “Ny”, where y is an index into Table 3. The results of evaluating the viable constraints on all of
the mutants with an observed phenotype are shown in Tables 4, 5, 6, and 7. Tables 4 and 5 show
the mutants that satisfied and did not satisfy the constraints, respectively, when the manually
obtained biological parameters were used. Tables 6 and 7 show the same for the mathematically
optimized biological parameters.
Table 4. Mutants that had no violated constraints, manually obtained parameters.
Wild type in glucose
Wild type in galactose
cln1∆ cln2∆
GAL-CLN2 cln1∆ cln2∆
cln1∆ cln2∆ sic1∆
cln1∆ cln2∆ cdh1∆
cln3∆
bck2∆
Multi-copy BCK2
cln3∆ bck2∆ GAL-CLN2 cln1∆ cln2∆
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cln1∆ cln2∆ cln3∆ GAL-CLN2
cln1∆ cln2∆ cln3∆ GAL-CLN3
cln1∆ cln2∆ cln3∆ sic1∆
cln1∆ cln2∆ cln3∆ cdh1∆
cln1∆ cln2∆ cln3∆ multi-copy CLB5
cln1∆ cln2∆ cln3∆ GAL-CLB5
cln1∆ cln2∆ cln3∆ multi-copy BCK2
sic1∆
GAL-SIC1
GAL-SIC1 GAL-CLN2 cln1∆ cln2∆
GAL-SIC1 GAL-CLN2 cln1∆ cln2∆ cdh1∆
sic1∆ cdh1∆ GALL-CDC20
cdh1∆
cdc6∆2-49
sic1∆ cdc6∆2-49
GAL-CLB2
Multicopy GAL-CLB2
CLB2-db∆
CLB2-db∆ in galactose
CLB2-db∆ multicopy SIC1
CLB2-db∆ GAL-SIC1
CLB2-db∆ clb5∆
CLB2-db∆ clb5∆ in galactose
clb5∆ clb6∆
GAL-CLB5
GAL-CLB5 cdh1∆
CLB5-db∆
tem1∆
GAL-TEM1
tem1-ts GAL-CDC15
tem1∆ net1-ts
tem1-ts multicopy CDC14
cdc15∆
Multicopy CDC15
cdc15∆ net1-ts
cdc15-tsmulticopy CDC14
net1-ts
GAL-NET1
cdc14-ts
GAL-NET1 GAL-CDC14
TAB6-1 cdc15∆
mad2∆
bub2∆
mad2∆ bub2∆
APC-A
APC-A cdh1∆
19
APC-A cdh1∆ GAL-SIC1
APC-A cdh1∆ GAL-CDC6
APC-A cdh1∆ multicopy CDC20
swi5∆
sic1∆ cdc6∆2-49 cdh1∆ GALL-CDC20
APC-A sic1∆
APC-A GAL-CLB2
Table 5. Mutants that had violated constraints, manually obtained parameters.
GAL-CLN2 cln1∆ cln2∆ cdh1∆ C3-N20, C4-N19, C4-N20, C5-N15, C5-N17,
C5-N20, C6-N15, C6-N17, C6-N20, C7-N15,
C7-N17, C7-N20, C8-N15, C8-N17, C8-N20
GAL-CLN3 C6-N1, C8-N11, C5-N19, C6-N13, C6-N17,
C7-N15, C7-N17, C8-N15, C8-N17
cln1∆ cln2∆ bck2∆ C8-N24
cdh1∆ cdc6∆2-49 C8-N10
GAL-CLB2 sic1∆ N12, N16
GAL-CLB2-db∆ N12
GAL-ESP1 cdc20-ts N5, N12
cdc14-ts GAL-SIC1 C1-N20, C2-N13, C2-N18, C2-N22, C3-N13,
C3-N18, C3-N22, C4-N13, C4-N18, C4-N22,
C5-N13, C5-N18, C5-N22, C6-N13, C6-N18,
C6-N22, C7-N13, C7-N18, C7-N22, C8-N13,
C8-N18, C8-N22
TAB6-1 C1-N8
TAB6-1 CLB1 clb2∆ C1-N17, C2-N15, C2-N17, C3-N15, C3-N17,
C4-N15, C4-N17, C5-N15, C5-N17, C6-N15,
C6-N17, C7-N15, C7-N17, C8-N15, C8-N17
APC-A cdh1∆ in galactose C1-N20, C2-N13, C2-N18, C2-N20, C2-N22,
C3-N13, C3-N18, C3-N20, C3-N22, C4-N13,
C4-N18, C4-N20, C4-N22, C5-N13, C5-N18,
C5-N20, C5-N22, C6-N13, C6-N18, C6-N20,
C6-N22, C7-N13, C7-N18, C7-N20, C7-N22,
C8-N13, C8-N18, C8-N20, C8-N22
APC-A cdh1∆ multicopy SIC1 C1-N17, C2-N15, C2-N17
APC-A cdh1∆ multicopy CDC6 C8-N11, C7-N22, C8-N13, C8-N18, C8-N22
Table 6. Mutants that had no violated constraints, optimized parameters.
Wild type in glucose
Wild type in galactose
cln1∆ cln2∆
GAL-CLN2 cln1∆ cln2∆
cln1∆ cln2∆ sic1∆
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cln1∆ cln2∆ cdh1∆
GAL-CLN2 cln1∆ cln2∆ cdh1∆
cln3∆
GAL-CLN3
bck2∆
Multi-copy BCK2
cln1∆ cln2∆ bck2∆
cln3∆ bck2∆ GAL-CLN2 cln1∆ cln2∆
cln1∆ cln2∆ cln3∆ GAL-CLN2
cln1∆ cln2∆ cln3∆ GAL-CLN3
cln1∆ cln2∆ cln3∆ sic1∆
cln1∆ cln2∆ cln3∆ cdh1∆
cln1∆ cln2∆ cln3∆ multi-copy CLB5
cln1∆ cln2∆ cln3∆ GAL-CLB5
cln1∆ cln2∆ cln3∆ multi-copy BCK2
sic1∆
GAL-SIC1
GAL-SIC1 GAL-CLN2 cln1∆ cln2∆
GAL-SIC1 GAL-CLN2 cln1∆ cln2∆ cdh1∆
sic1∆ cdh1∆ GALL-CDC20
cdh1∆
cdc6∆2-49
sic1∆ cdc6∆2-49
GAL-CLB2
Multicopy GAL-CLB2
CLB2-db∆
CLB2-db∆ GAL-SIC1
CLB2-db∆ clb5∆
CLB2-db∆ clb5∆ in galactose
clb5∆ clb6∆
GAL-CLB5
GAL-CLB5 cdh1∆
CLB5-db∆
tem1∆
GAL-TEM1
tem1-ts GAL-CDC15
tem1∆ net1-ts
tem1-ts multicopy CDC14
cdc15∆
Multicopy CDC15
cdc15∆ net1-ts
cdc15-tsmulticopy CDC14
GAL-NET1
cdc14-ts
GAL-NET1 GAL-CDC14
TAB6-1
21
TAB6-1 cdc15∆
TAB6-1 CLB1 clb2∆
mad2∆
bub2∆
APC-A
APC-A cdh1∆
APC-A cdh1∆ in galactose
APC-A cdh1∆ multicopy SIC1
APC-A cdh1∆ GAL-SIC1
APC-A cdh1∆ multicopy CDC6
APC-A cdh1∆ GAL-CDC6
APC-A cdh1∆ multicopy CDC20
swi5∆
APC-A sic1∆
APC-A GAL-CLB2
Table 7. The mutants that had violated constraints, optimized parameters.
cdh1∆ cdc6∆2-49 C8-N10
GAL-CLB2 sic1∆ N12, N16
CLB2-db∆ in galactose N16
CLB2-db∆ multicopy SIC1 C8-N22, C8-N25
GAL-CLB2-db∆ N12
GAL-ESP1 cdc20-ts N5, N12
net1-ts C1-N8
cdc14-ts GAL-SIC1 C1-N20, C2-N13, C2-N18, C2-N22, C3-N13,
C3-N18, C3-N22, C4-N13, C4-N18, C4-N22,
C5-N13, C5-N18, C5-N22, C6-N13, C6-N18,
C6-N22, C7-N13, C7-N18, C7-N22, C8-N13,
C8-N18, C8-N22
mad2∆ bub2∆ C1-N16
sic1∆ cdc6∆2-49 cdh1∆ GALL-CDC20 C1-N16, C1-N18
A parallel direct search algorithm [18] applied to the penalty function formulation used over
10,000 CPU hours on 400 processors of a 2200 processor supercomputer (1100 Apple G5 Xserve
nodes, Infiniband network). The full inequality formulation for all mutants would have approxi-
mately 11,500 constraints (sum of constraints per phenotype accounting for multiple cycles) and
4000 variables (almost all of them times t
{i}
j ). One ODE solution and the transforms necessary to
match the ODE solution to experimental data take about 17 seconds on a 2.3 GHz G5 processor,
so the need for parallel supercomputing is clear. While the nonlinear inequality formulation is
definitely large scale, it is well within the range of problems being solved in industry. This work
demonstrates the reasonableness of the inequality approach to parameter estimation for cell cycle
modeling. Mechanically assembling all 11,500 constraints and then solving the feasibility problem
will be a major undertaking requiring several man-years of effort and parallel supercomputing to
evaluate the constraints, but is surely doable.
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6. Conclusions
A long-range goal of system biology is to develop efficient tools for fitting quantitative models to
available types of experimental data. The cell cycle control system in budding yeast is a represen-
tative example of this general problem. The model consists of 36 variable protein levels (described
by ordinary differential equations) and 143 kinetic parameters that need to be estimated from the
data. The data consists of a hodge-podge of qualitative observations and quantitative measure-
ments on wild-type and mutant cells. The challenge is to determine if there exists a feasible set
of kinetic parameters for which the ODEs are consistent with the qualitative phenotypes of the
collection of mutants.
This problem is formulated as a system of nonlinear inequalities that is satisfied if and only
if the model matches all experimental data. The results in Tables 4–7 show that this formulation
can accurately compare the simulation results with the experimental data. Using the smooth
constraints instead of the discontinuous objective function will make it possible to use mathematical
programming algorithms that assume smooth functions.
Note that no 143-dimensional parameter vector is known that will satisfy all the constraints
because some experimental data may be wrong, the ODE model may be incomplete, and/or the
biologically correct parameter vector may not yet have been found. Regardless of the source of
the discrepancy, this inequality formulation provides a qualitatively different approach from the
discontinuous penalty function for biologists to use in their quest for a validated cell cycle model.
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8. Appendix A: Mutants
Mutants marked by an asterisk (*) have a phenotype that does not correspond to any of the
constraint sets given in Section 3.
Index Mutant name Observed Phenotype
1. Wild type in glucose Viable, G1 = 35.2
2. Wild type in galactose Viable, G1 = 109
3. cln1∆ cln2∆ Viable, M = 2wm
4. GAL-CLN2 cln1∆ cln2∆ Viable, M = 0.5wm
5. cln1∆ cln2∆ sic1∆ Viable
6. cln1∆ cln2∆ cdh1∆ Viable
7. GAL-CLN2 cln1∆ cln2∆ cdh1∆ Viable, M = 1.7wm
8. cln3∆ Viable, M = 1.7wm
9. GAL-CLN3 Viable, M = 0.44wm
10. bck2∆ Viable, M = 1.4wm
11. Multi-copy BCK2 Viable, M = 0.8wm
12. cln1∆ cln2∆ bck2∆ Viable, M = 1.7wm
13. cln3∆ bck2∆ G1 arrest
14. cln3∆ bck2∆ GAL-CLN2 cln1∆ cln2∆ Viable
15. cln3∆ bck2∆ multi-copy CLN2 G1 arrest
16. cln3∆ bck2∆ GAL-CLB5 Inviable
17. cln3∆ bck2∆ sic1∆ Inviable
18. cln1∆ cln2∆ cln3∆ G1 arrest
19. cln1∆ cln2∆ cln3∆ GAL-CLN2 Viable
20. cln1∆ cln2∆ cln3∆ GAL-CLN3 Viable
21. cln1∆ cln2∆ cln3∆ sic1∆ Viable, G1 = 10, M = 3.5wm
22. cln1∆ cln2∆ cln3∆ cdh1∆ Telophase arrest
23. cln1∆ cln2∆ cln3∆ multi-copy CLB5 Viable
24. cln1∆ cln2∆ cln3∆ GAL-CLB5 Viable
25. cln1∆ cln2∆ cln3∆ multi-copy BCK2 Viable
26. cln1∆ cln2∆ cln3∆ GAL-CLB2 G1 arrest
27. cln1∆ cln2∆ cln3∆ apc-ts Metaphase arrest
28. sic1∆ Viable, G1 = 15, M = wm
29. GAL-SIC1 Viable, G1 = 135, M = 2wm
30. GAL-SIC1-db∆ G1 arrest
31. GAL-SIC1 cln1∆ cln2∆ G1 arrest
32. GAL-SIC1 cln1∆ cln2∆ cdh1∆ G1 arrest
33. GAL-SIC1 GAL-CLN2 cln1∆ cln2∆ Viable
34. GAL-SIC1 GAL-CLN2 cln1∆ cln2∆ cdh1∆ Viable
35. sic1∆ cdh1∆ Reductive mitosis in second cycle*
36. sic1∆ cdh1∆ GALL-CDC20 Viable
37. cdh1∆ Viable, M = 0.6wm
38. Cdh1 constitutively active G2 arrest
39. cdc6∆2-49 Viable
40. sic1∆ cdc6∆2-49 Viable
41. cdh1∆ cdc6∆2-49 Viable, G1 = 20, M = 2wm
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42. clb1∆ clb2∆ G2 arrest
43. GAL-CLB2 Viable
44. Multicopy GAL-CLB2 Telophase arrest
45. GAL-CLB2 sic1∆ Telophase arrest
46. GAL-CLB2 cdh1∆ Inviable
47. CLB2-db∆ Telophase arrest
48. CLB2-db∆ in galactose Telophase arrest
49. CLB2-db∆ multicopy SIC1 Viable
50. CLB2-db∆ GAL-SIC1 Viable
51. CLB2-db∆ clb5∆ Telophase arrest
52. CLB2-db∆ clb5∆ in galactose Viable
53. GAL-CLB2-db∆ Telophase arrest
54. clb5∆ clb6∆ Viable, G1 = 65
55. cln1∆ cln2∆ clb5∆ clb6∆ G1 arrest
56. GAL-CLB5 Viable
57. GAL-CLB5 sic1∆ Inviable
58. GAL-CLB5 cdh1∆ Inviable after many divisions*
59. CLB5-db∆ Viable
60. CLB5-db∆ sic1∆ Semi-lethal*
61. CLB5-db∆ pds1∆ Viable
62. CLB5-db∆ pds1∆ cdc20∆ Telophase arrest
63. GAL-CLB5-db∆ Inviable
64. cdc20-ts Metaphase arrest
65. cdc20∆ clb5∆ Metaphase arrest
66. cdc20∆ pds1∆ Telophase arrest
67. cdc20∆ pds1∆ clb5∆ Viable
68. GAL-CDC20 Premature chromosome separation*
69. cdc20-ts mad2∆ Metaphase arrest
70. cdc20-ts bub2∆ Metaphase arrest
71. pds1∆ Viable
72. esp1-ts Chromosome separation failure*
73. PDS1-db∆ Chromosome separation failure*
74. GAL-PDS1-db∆ Chromosome separation failure*
75. GAL-PDS1-db∆ esp1-ts Chromosome separation failure*
76. GAL-ESP1 cdc20-ts Telophase arrest
77. tem1∆ Telophase arrest
78. GAL-TEM1 Viable
79. tem1-ts GAL-CDC15 Viable
80. tem1∆ net1-ts Viable
81. tem1-ts multicopy CDC14 Viable
82. cdc15∆ Telophase arrest
83. Multicopy CDC15 Viable
84. cdc15-ts multicopy TEM1 Inviable
85. cdc15∆ net1-ts Viable
86. cdc15-ts multicopy CDC14 Viable
87. net1-ts Viable, G1 = 50
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88. GAL-NET1 Telophase arrest
89. cdc14-ts Telophase arrest
90. GAL-CDC14 G1 arrest
91. GAL-NET1 GAL-CDC14 Viable
92. net1∆ cdc20-ts Reductive mitosis*
93. cdc14-ts GAL-SIC1 Weakly viable*
94. TAB6-1 Viable
95. TAB6-1 cdc15∆ Viable
96. TAB6-1 clb5∆ clb6∆ G1 arrest
97. TAB6-1 CLB1 clb2∆ Viable
98. mad2∆ Viable, G1 = 35, M = wm
99. bub2∆ Viable, G1 = 35, M = wm
100. mad2∆ bub2∆ Viable
101. APC-A Viable, G1 = 20, M = 1.5wm
102. APC-A cdh1∆ Telophase arrest
103. APC-A cdh1∆ in galactose Viable
104. APC-A cdh1∆ multicopy SIC1 Viable
105. APC-A cdh1∆ GAL-SIC1 Viable
106. APC-A cdh1∆ multicopy CDC6 Viable
107. APC-A cdh1∆ GAL-CDC6 Viable
108. APC-A cdh1∆ multicopy CDC20 Viable
109. swi5∆ Viable, G1 = 20
110. sic1∆ cdc6∆2-49 cdh1∆ G2 arrest in second cycle
111. sic1∆ cdc6∆2-49 cdh1∆ GALL-CDC20 Viable
112. APC-A cdh1∆ clb5∆ Inviable
113. APC-A cdh1∆ pds1∆ Inviable
114. APC-A sic1∆ Viable
115. APC-A GAL-CLB2 Telophase arrest
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